MedTrace Logo

C15:0 Supplementation in Young Adults at Risk for Metabolic Syndrome

NCT04947176 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2023-06-05

No results posted yet for this study

Summary

This study will determine changes in plasma C15:0 levels in young adults with BMI ≥ 25 in response to 12 weeks of daily oral C15:0 supplementation.

Conditions

  • Metabolic Syndrome

Interventions

DIETARY_SUPPLEMENT

Supplement

200mg C15:0 once daily

OTHER

Placebo

Matching placebo once daily

Sponsors & Collaborators

  • Jeffrey B. Schwimmer, MD

    lead OTHER

Principal Investigators

  • Jeffrey Schwimmer, MD · UC San Diego

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
25 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-07-06
Primary Completion
2023-04-30
Completion
2023-12-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04947176 on ClinicalTrials.gov